Status:
COMPLETED
Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea
Lead Sponsor:
University of South Florida
Conditions:
Post-COVID-19 Syndrome
Dyspnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the extent to which a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory breathing exercises compared to expiratory breathing exercises alone will help to ...
Detailed Description
To evaluate the extent to which a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory muscle strength training exercises as compared to a prior study of expiratory musc...
Eligibility Criteria
Inclusion
- Self-reported history of a positive COVID-19 diagnosis in the past.
- Able to walk independently
- Cognitively intact
- English-speaking
- Dyspnea at rest or with activity rated at 3 or greater on the Dyspnea on Exertion scale.
- May use oxygen.
- May be taking medications.
Exclusion
- Individuals who are wheelchair bound or who cannot walk independently.
- Individuals hospitalized for COVID-19 who self-report that they received mechanical ventilation during hospitalization.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 14 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06091280
Start Date
December 1 2023
End Date
March 14 2025
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida
Tampa, Florida, United States, 33620